Introducing the Australasian PF Trial Site Feasibility Index
Accelerating Clinical Trials. Expanding Possibilities.
At PACT, one of our core missions is to implement resources to maximise local PF clinical trial activity and capacity.
One of the challenges faced is that before a trial can begin a pivotal question must be answered – what sites will be able to successfully conduct the trial?
That question, however straightforward it sounds, hides a complex and resource‐intensive process. Sponsors must identify sites that possess the right infrastructure, staff, participant pools, and technology. And sites themselves need to understand both sponsor expectations and their own capabilities — to decide whether pursuing a trial is viable. It’s a process that can be costly, time‐consuming, and fraught with uncertainty.
The clinical trial feasibility assessment process is one that can be costly, time‐consuming, and involves a measure of uncertainty.
Until now……..
What is the Australasian PF Trial Site Feasibility Index?
We are excited to launch a unique, PACT-developed platform that simplifies and streamlines the feasibility data collection process.
This tool will dramatically reduce repetitive, unnecessary paperwork, eliminate early‐stage back and forth communication, and focus effort where it truly counts.
The aim of the Feasibility Index is to:
- Guide trial site contact so that it is more targeted, with sponsors and CROs only offering participation to sites with capabilities relevant to their planned trial.
- Enable a broader range of trial sites to be visible to sponsors and CROs, bringing trial participation to sites and regions beyond the traditional expert centres, thus helping to improve equity of access.